You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

Lofexidine hydrochloride - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic sources for lofexidine hydrochloride and what is the scope of freedom to operate?

Lofexidine hydrochloride is the generic ingredient in two branded drugs marketed by Indoco and Uswm, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

Four suppliers are listed for this compound.

Summary for lofexidine hydrochloride
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Finished Product Suppliers / Packagers: 4
Raw Ingredient (Bulk) Api Vendors: 68
Clinical Trials: 42
Patent Applications: 271
What excipients (inactive ingredients) are in lofexidine hydrochloride?lofexidine hydrochloride excipients list
DailyMed Link:lofexidine hydrochloride at DailyMed
Recent Clinical Trials for lofexidine hydrochloride

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
USWM, LLC (dba US WorldMeds)Phase 2
BioXcel Therapeutics IncPhase 1/Phase 2
National Institute on Drug Abuse (NIDA)Phase 1/Phase 2

See all lofexidine hydrochloride clinical trials

Anatomical Therapeutic Chemical (ATC) Classes for lofexidine hydrochloride

US Patents and Regulatory Information for lofexidine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Uswm LUCEMYRA lofexidine hydrochloride TABLET;ORAL 209229-001 May 16, 2018 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Indoco LOFEXIDINE HYDROCHLORIDE lofexidine hydrochloride TABLET;ORAL 218613-001 Aug 20, 2024 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.